CTOs on the Move

Acer Therapeutics

www.acertx.com

 
Acer Therapeutics is a biotech company, headquartered in Cambridge, MA, that develops repurposed and reformulated medicines for the treatment of ultra-orphan diseases with significant unmet medical needs. Acer`s lead candidate, EDVISO™ (celiprolol), is the first pharmaceutical therapy seeking approval for patients with vascular-type Ehlers-Danlos syndrome (vEDS). Ehlers-Danlos Syndrome is a group of hereditary disorders of connective tissue with no ethnic predisposition. vEDS is a subtype characterized by severe arterial dissections, ruptures and early death. Complications are rare in childhood, but affect 25% of patients before the age of 20, and 80% by the age of 40. Median age of death ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.acertx.com
  • One Gateway Center, Suite 351 300 Washington Street
    Newton, MA USA 02458
  • Phone: 844.902.6100

Executives

Name Title Contact Details

Funding

Acer Therapeutics raised $48M on 03/07/2022

Similar Companies

Maclean Health

Maclean Health is a medical and pharmaceutical products wholesale distributor that specializes in supplying market innovators to government and private healthcare partners.

NS Pharma

NS Pharma is a biopharmaceutical company focused on researching and developing treatments for rare diseases, with a current focus on optimizing exon skipping therapy for Duchenne muscular dystrophy.

THE PLANNING SHOP International

THE PLANNING SHOP International is a Jamison, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ABcann Global

Our group of companies will be the first to produce repeatable, standardized, plant-based medicines worldwide. ABcann will produce products with integrity in a customer focused culture where social responsibility and environmental impacts are mandated.